Efficacy of Osimertinib in Patients With Lung Cancer

Hunan Province Tumor Hospital

Status: Enrolling

Conditions: Advanced Non-Small Cell Lung Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT06174857

EGFR 19 delins

Details and patient eligibility

About

This is a descriptive observational study, in which data are collected in an epidemiological fashion and prospective. This study does not intend to intervene the current medical practice of the recruited patients.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients must be ≥18 years.
• Provision of fully informed consent prior to any study specific procedures.
• Advanced or metastatic lung squamous cell carcinoma confirmed by histology or cytology.
• According to the RECIST 1.1 standard, the patient must have at least one measurable lesion.

Exclusion criteria

• None